The wearable artificial kidney (WAK) is a device that allows prolonged and frequent dialysis treatments for patients with end stage renal disease. It potentially provides a practical and feasible solution to satisfy the need for an optimal delivered dialysis. Until now, the WAK has already been presented in several models, proposing different therapeutic modalities and engineering approaches. The ideal solution of a WAK may come from a combination of all the prototypes developed and/or those currently in development. Consequently, it is important to have a complete overview and a deep knowledge of the possible engineering solutions in order to achieve the incremental steps necessary to solve the remaining issues of wearable extracorporeal blood purification devices. Since technical advances are continuously evolving and it is important to focus on clinical requirements and needs, a multidisciplinary collaboration has to be coordinated to achieve the final objective of the practical realization of a wearable artificial kidney. In such a context, the main aim of this article was to analyze more in detail the WAK Engineeristic Development.

Keywords:
Wearable artificial kidney, WAK latest developments, Miniaturization, Pumps for extracorporeal circulation
1.
Meguid El Nahas A, Bello AK: Chronic kidney disease: the global challenge. Lancet 2005;365:331-340.
2.
Environmental health: Gold, mercury and health. Wkly Epidemiol Rec 1994;69:275-278.
3.
Winearls CG, Haynes R, Glassock R: CKD staging - evolution not revolution. Nefrologia 2010;30:493-500.
4.
Lee CP, Zenios SA, Chertow GM: Cost-effectiveness of frequent in-center hemodialysis. J Am Soc Nephrol 2008;19:1792-1797.
5.
Kim JC, Ronco C: Current technological approaches for a wearable artificial kidney. Contrib Nephrol 2011;171:231-236.
6.
Kim JC, et al: A wearable artificial kidney: technical requirements and potential solutions. Expert Rev Med Devices 2011;8:567-579.
7.
Fissell WH, Roy S, Davenport A: Achieving more frequent and longer dialysis for the majority: wearable dialysis and implantable artificial kidney devices. Kidney Int 2013;84:256-264.
8.
Ronco C, Fecondini L: The Vicenza wearable artificial kidney for peritoneal dialysis (ViWAK PD). Blood Purif 2007;25:383-388.
9.
Lee DB, Roberts M: A peritoneal-based automated wearable artificial kidney. Clin Exp Nephrol 2008;12:171-180.
10.
Humes HD, et al: Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 1999;55:2502-2514.
11.
Humes HD, et al: Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004;66:1578-1588.
12.
Nissenson AR: Bottom-up nanotechnology: the human nephron filter. Semin Dial 2009;22:661-664.
13.
Fissell WH, Roy S: The implantable artificial kidney. Semin Dial 2009;22:665-670.
14.
Nissenson AR, et al: The human nephron filter: toward a continuously functioning, implantable artificial nephron system. Blood Purif 2005;23:269-274.
15.
Ronco C, Davenport A, Gura V: The future of the artificial kidney: moving towards wearable and miniaturized devices. Nefrologia 2011;31:9-16.
16.
Kang J, Scholz T, Weaver JD, Ku DN, Rosen DW: Pump design for a portable renal replacement system. J Med Devices 2011;5:031008.
18.
Gura V, et al: Continuous renal replacement therapy for end-stage renal disease. The wearable artificial kidney (WAK). Contrib Nephrol 2005;149:325-333.
19.
Gura V, et al: Technical breakthroughs in the wearable artificial kidney (WAK). Clin J Am Soc Nephrol 2009;4:1441-1448.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.